310442-94-5 Usage
Uses
Used in Pharmaceutical Synthesis:
Ethyl 4-chloro-5-ethylpyrazole-3-carboxylate is used as a key intermediate in the synthesis of various pharmaceuticals. Its unique structure allows for the development of new drugs with specific therapeutic properties, contributing to advancements in medicinal chemistry.
Used in Agricultural Product Synthesis:
In the agricultural industry, Ethyl 4-chloro-5-ethylpyrazole-3-carboxylate serves as a building block for the creation of agrochemicals, such as pesticides and herbicides. Its incorporation into these products can enhance their effectiveness in controlling pests and weeds, thereby improving crop yields and quality.
Used as a Research Reagent in Biochemical Studies:
Due to its potential biological activity, Ethyl 4-chloro-5-ethylpyrazole-3-carboxylate is utilized as a research reagent in biochemical studies. It can be employed to investigate various biological processes and interactions, providing valuable insights into the development of new therapeutic agents and understanding the underlying mechanisms of diseases.
Check Digit Verification of cas no
The CAS Registry Mumber 310442-94-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,1,0,4,4 and 2 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 310442-94:
(8*3)+(7*1)+(6*0)+(5*4)+(4*4)+(3*2)+(2*9)+(1*4)=95
95 % 10 = 5
So 310442-94-5 is a valid CAS Registry Number.
310442-94-5Relevant academic research and scientific papers
Pyrrolotriazine inhibitors of kinases
-
Page/Page column 94, (2008/06/13)
The present invention provides compounds of formula I and pharmaceutically acceptable salts thereof. The formula I compounds inhibit the tyrosine kinase activity of growth factor receptors such as VEGFR-2, FGFR-1, PDGFR, HER-1, HER-2, thereby making them useful as anti-cancer agents. The formula I compounds are also useful for the treatment of other diseases associated with signal transduction pathways operating through growth factor receptors.
New dual inhibitors of EGFR and HER2 protein tyrosine kinases
Fink, Brian E.,Vite, Gregory D.,Mastalerz, Harold,Kadow, John F.,Kim, Soong-Hoon,Leavitt, Kenneth J.,Du, Karen,Crews, Donald,Mitt, Toomas,Wong, Tai W.,Hunt, John T.,Vyas, Dolatrai M.,Tokarski, John S.
, p. 4774 - 4779 (2007/10/03)
A novel series of dual EGFR and HER2 inhibitors based on the pyrrolo[2,1-f][1,2,4]triazine nucleus is described. A general route toward their synthesis, which enables functionalization at multiple sites, has been developed. Biological evaluation in enzyma
